Figure 3From: Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis Effect of LAM + ADV vs. ETV at 96 weeks on virologic response. Back to article page